中文 | EN
ABOUT US

About GenoMatrix™

GenoMatrix Technology (Shanghai) Co., Ltd. — The world's leading equine genomics technology provider, building genomic data infrastructure for the global equine industry.

🎯 Who We Are

GenoMatrix is the world's leading equine genomics technology provider. Built on the EquCab 3.0 reference genome, we have constructed the most comprehensive equine variant database to date and developed the proprietary NCDS v3.4 model for precise genotype-to-phenotype prediction. Our Jump™ product suite covers five core domains: hereditary disease screening, genetic identity verification, causal regulatory networks, athletic aptitude classification, and functional hierarchy systems.

🔭 Mission & Vision

Mission: Decode to Decide. From genome to racetrack performance, from DNA to commercial decisions. We empower every equine industry stakeholder to make smarter decisions grounded in genomic data.

Vision: Becoming the genomic data infrastructure for the global equine industry. With 6.2 million+ horses in China alone, we are building the "utilities" of genomic data — serving the entire equine value chain with infrastructure-grade genomic intelligence.

💎 Core Value Propositions

1. Unmatched Scientific Rigor
Every variant annotated with multi-layered evidence — VEP, SIFT, PolyPhen-2, and experimental validation. 90% core gene verification rate. 27 capabilities with undisputed global leadership.

2. Independent Third-Party Verification
Genomics-powered verification for equine transactions — hereditary disease risk, pedigree authenticity, and athletic potential assessment as a neutral, data-driven third party.

3. API-First, Asset-Light Model
Data + Algorithms + API as core deliverables. SaaS-genomics — access world-class genetic analysis capabilities without heavy laboratory infrastructure.

🏗️ Milestones

2024

Project Inception

Equine whole-genome variant database construction initiated on the EquCab 3.0 reference genome.

2025

Database Maturity

40.15M+ variant positions ingested across 982 data tables. Full VEP/SIFT/PolyPhen annotation pipeline completed. NCDS v3.4 model development finalized.

2025 Q4

Product Suite Launch

Five-product Jump™ suite officially launched: JumpHealth, JumpID, JumpChain, JumpSport, JumpHierarchy.

2026

Global Expansion

API platform live with 400+ breed coverage. 60 patent applications filed. Bilingual website launched.

📊 By the Numbers

40.15M+ variants · 852K VEP transcripts · 885K SIFT/PolyPhen dual coverage · 49,697 causal variants · 5,178 network nodes · 125,342 regulatory edges · 400+ breeds · 22GB database · 60,512 chr1 speed gene cluster SNPs · 102-gene NCDS architecture · 90% core gene validation · 7 sport scoring engines · 60 patents · 25 breed-specific panels · 33 specialized capabilities · 27 globally leading capabilities